FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

38112003: 1 (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    64719019 One en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442105014 1 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    1 Is a General adjectival modifier false Inferred relationship Some
    1 Is a Number false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Telbivudine 20 mg/mL oral solution Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely cefotetan (as cefotetan disodium) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely cefotetan (as cefotetan disodium) 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely omeprazole (as omeprazole magnesium) 10 milligram/1 each gastro-resistant oral capsule (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely omeprazole (as omeprazole magnesium) 10 milligram/1 each gastro-resistant oral capsule (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Cocaine 100 mg/g nasal paste Count of base of active ingredient False 1 Inferred relationship Some
    Cocaine 100 mg/g nasal paste Has concentration strength denominator value False 1 Inferred relationship Some 1
    Citalopram (as citalopram hydrobromide) 20 mg orodispersible tablet Count of base of active ingredient False 1 Inferred relationship Some
    Citalopram (as citalopram hydrobromide) 20 mg orodispersible tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Clostridium histolyticum collagenase 900 microgram powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Clostridium histolyticum collagenase 900 microgram powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Ibuprofen 40 mg/mL oral suspension Has concentration strength denominator value False 1 Inferred relationship Some 1
    Ibuprofen 40 mg/mL oral suspension Count of base of active ingredient False 1 Inferred relationship Some
    Amoxicillin 125 mg and clavulanic acid (as clavulanate potassium) 31.2 mg chewable tablet Has presentation strength denominator value False 1 Inferred relationship Some 2
    Amoxicillin 125 mg and clavulanic acid (as clavulanate potassium) 31.2 mg chewable tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely omeprazole 20 milligram/1 each gastro-resistant oral capsule (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely omeprazole 20 milligram/1 each gastro-resistant oral capsule (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Calcium electrolyte 1.25 g and colecalciferol 10 microgram chewable tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Calcium electrolyte 1.25 g and colecalciferol 10 microgram chewable tablet Has presentation strength denominator value False 1 Inferred relationship Some 2
    Product containing precisely baclofen 10 milligram/1 each conventional release orodispersible tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely baclofen 10 milligram/1 each conventional release orodispersible tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely potassium chloride 1.875 gram/1 sachet powder for conventional release oral solution (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely potassium chloride 1.875 gram/1 sachet powder for conventional release oral solution (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Estradiol 100 mg prolonged-release subcutaneous implant Has presentation strength denominator value False 1 Inferred relationship Some 1
    Estradiol 100 mg prolonged-release subcutaneous implant Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely terbutaline sulfate 1 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength numerator value False 1 Inferred relationship Some 1
    Product containing precisely terbutaline sulfate 1 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely terbutaline sulfate 1 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely ganciclovir 4.5 milligram/1 each prolonged-release ocular implant (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely ganciclovir 4.5 milligram/1 each prolonged-release ocular implant (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Sevelamer carbonate 2.4 g powder for oral suspension sachet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Sevelamer carbonate 2.4 g powder for oral suspension sachet Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely plerixafor 20 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely plerixafor 20 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely acetazolamide 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely acetazolamide 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely glyceryl trinitrate 400 microgram/1 hour prolonged-release transdermal patch (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely glyceryl trinitrate 400 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely macrogol 3350 17 gram/1 sachet powder for conventional release oral solution (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely macrogol 3350 17 gram/1 sachet powder for conventional release oral solution (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely omeprazole 40 milligram and sodium bicarbonate 1.68 gram/1 sachet powder for conventional release oral suspension (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 2
    Product containing precisely omeprazole 40 milligram and sodium bicarbonate 1.68 gram/1 sachet powder for conventional release oral suspension (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely glyceryl trinitrate 600 microgram/1 hour prolonged-release transdermal patch (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely glyceryl trinitrate 600 microgram/1 hour prolonged-release transdermal patch (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Diazepam 2 mg/mL rectal solution Count of base of active ingredient False 1 Inferred relationship Some
    Diazepam 2 mg/mL rectal solution Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely diazepam 4 milligram/1 milliliter conventional release rectal solution (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely diazepam 4 milligram/1 milliliter conventional release rectal solution (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely omeprazole 20 milligram and sodium bicarbonate 1.68 gram/1 sachet powder for conventional release oral suspension (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 2
    Product containing precisely omeprazole 20 milligram and sodium bicarbonate 1.68 gram/1 sachet powder for conventional release oral suspension (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Risperidone 12.5 mg powder for suspension for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Risperidone 12.5 mg powder for suspension for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Mesalazine 66.7 mg/mL rectal suspension Count of base of active ingredient False 1 Inferred relationship Some
    Mesalazine 66.7 mg/mL rectal suspension Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely certolizumab pegol 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely certolizumab pegol 200 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely risperidone 25 milligram/1 vial powder for conventional release suspension for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely risperidone 25 milligram/1 vial powder for conventional release suspension for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely tenecteplase 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely tenecteplase 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely zoledronic acid 4 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely zoledronic acid 4 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely risperidone 37.5 milligram/1 vial powder for conventional release suspension for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely risperidone 37.5 milligram/1 vial powder for conventional release suspension for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Colesevelam hydrochloride 1.875 g powder for oral suspension sachet Count of base of active ingredient False 1 Inferred relationship Some
    Colesevelam hydrochloride 1.875 g powder for oral suspension sachet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely temozolomide 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely temozolomide 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Risperidone 50 mg powder for suspension for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Risperidone 50 mg powder for suspension for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Levonorgestrel 75 mg prolonged-release subcutaneous implant Count of base of active ingredient False 1 Inferred relationship Some
    Levonorgestrel 75 mg prolonged-release subcutaneous implant Has presentation strength denominator value False 1 Inferred relationship Some 1
    Fentanyl 12 microgram/hour prolonged-release transdermal patch Has concentration strength denominator value False 1 Inferred relationship Some 1
    Fentanyl 12 microgram/hour prolonged-release transdermal patch Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely colesevelam hydrochloride 3.75 gram/1 sachet powder for conventional release oral suspension (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely colesevelam hydrochloride 3.75 gram/1 sachet powder for conventional release oral suspension (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Sodium benzoate 100 mg/mL and sodium phenylacetate 100 mg/mL solution for injection Has concentration strength denominator value False 1 Inferred relationship Some 1
    Sodium benzoate 100 mg/mL and sodium phenylacetate 100 mg/mL solution for injection Has concentration strength denominator value False 1 Inferred relationship Some 2
    Sotalol hydrochloride 15 mg/mL solution for injection Has concentration strength denominator value False 1 Inferred relationship Some 1
    Sotalol hydrochloride 15 mg/mL solution for injection Count of base of active ingredient False 1 Inferred relationship Some
    Ixabepilone 15 mg powder for solution for injection vial Count of base of active ingredient False 1 Inferred relationship Some
    Ixabepilone 15 mg powder for solution for injection vial Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely pegloticase 8 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely pegloticase 8 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Sevelamer carbonate 800 mg powder for oral suspension sachet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Sevelamer carbonate 800 mg powder for oral suspension sachet Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely ixabepilone 45 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely ixabepilone 45 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Colestyramine 4 g powder for oral suspension sachet Count of base of active ingredient False 1 Inferred relationship Some
    Colestyramine 4 g powder for oral suspension sachet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Cabazitaxel 40 mg/mL solution for injection Has concentration strength denominator value False 1 Inferred relationship Some 1
    Cabazitaxel 40 mg/mL solution for injection Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely interferon beta-1b 300 microgram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely interferon beta-1b 300 microgram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Ecallantide 10 mg/mL solution for injection Count of base of active ingredient False 1 Inferred relationship Some
    Ecallantide 10 mg/mL solution for injection Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely pemetrexed (as pemetrexed disodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely pemetrexed (as pemetrexed disodium) 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely sodium para-aminohippurate 200 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely sodium para-aminohippurate 200 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Glyceryl trinitrate 800 microgram/hour prolonged-release transdermal patch Count of base of active ingredient False 1 Inferred relationship Some

    Start Previous Page 185 of 215 Next End

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start